Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
GLI3
REST API REST API
Homo sapiens
GLI3 is differentially expressed in 262 experiments: 137 organism parts: lung, liver, ... (135 more);, 159 disease states: normal, prostate carcinoma, ... (157 more);, 95 cell types 409 cell lines 32 compound treatments and 74 other conditions.
Synonyms PAPA, GCPS, PAP-A, PAPA1, PPDIV, PHS, PAPB, ACLS
Orthologs GLI3 (Bos taurus)   GLI3 (Gallus gallus)   gli3 (Danio rerio)   Gli3 (Rattus norvegicus)   Q4H3F1_CIOIN (Ciona intestinalis)   Gli3 (Mus musculus)   gli3 (Xenopus laevis)   GLI3 (Canis familiaris)   (Compare orthologs)
Gene Ontology Term hindgut morphogenesis, cytosol, pattern specification process, transcriptional repressor complex, negative regulation of transcription, DNA-dependent, protein binding, regulation of transcription, DNA-dependent, cytoplasm, beta-catenin binding, regulation of cell proliferation, intracellular, negative regulation of cell proliferation, embryonic digestive tract development, transcription, DNA-dependent, negative regulation of smoothened signaling pathway, developmental growth, negative regulation of apoptosis, metal ion binding, embryonic morphogenesis, proximal/distal pattern formation, smoothened signaling pathway, intracellular membrane-bounded organelle, histone deacetylase binding, positive regulation of neuroblast proliferation, sequence-specific DNA binding, axon guidance, positive regulation of transcription from RNA polymerase II promoter, nucleus, protein processing, heart development, regulation of gene expression, regulation of cell differentiation, histone acetyltransferase binding, chromatin binding, negative regulation of transcription from RNA polymerase II promoter, negative regulation of cell differentiation, cilium, brain development, mediator complex, positive regulation of transcription, DNA-dependent, nucleolus, central nervous system development, zinc ion binding, regulation of apoptosis, dorsal/ventral pattern formation, negative regulation of alpha-beta T cell differentiation, optic nerve morphogenesis, smoothened signaling pathway involved in spinal cord motor neuron cell fate specification, oligodendrocyte differentiation, subpallium development, limb morphogenesis, frontal suture morphogenesis, smoothened signaling pathway involved in dorsal/ventral neural tube patterning, in utero embryonic development, kidney development, telencephalon development, branching involved in ureteric bud morphogenesis, pallium development, negative thymic T cell selection, positive regulation of chondrocyte differentiation, limb development, camera-type eye morphogenesis, inner ear development, forebrain development, mammary gland development, melanocyte differentiation, positive regulation of protein import into nucleus, embryonic skeletal system morphogenesis, anatomical structure development, anatomical structure formation involved in morphogenesis, branching morphogenesis of a tube, positive regulation of alpha-beta T cell differentiation, metanephros development, smoothened signaling pathway involved in ventral spinal cord interneuron specification, embryonic digit morphogenesis, embryonic digestive tract morphogenesis, negative regulation of neuron differentiation, artery development, anterior semicircular canal development, lateral semicircular canal development, neural tube development, lung development, mammary gland specification, camera-type eye development, positive regulation of osteoblast differentiation, neuron fate commitment, palate development, tube development, odontogenesis of dentine-containing tooth, tongue development, embryonic limb morphogenesis, negative regulation of canonical Wnt receptor signaling pathway, spinal cord dorsal/ventral patterning, forebrain dorsal/ventral pattern formation, sequence-specific DNA binding transcription factor activity, T cell differentiation in thymus, sagittal suture morphogenesis, forebrain radial glial cell differentiation, cerebral cortex radial glia guided migration, lambdoid suture morphogenesis, cell differentiation involved in kidney development, lateral ganglionic eminence cell proliferation, thymocyte apoptosis, anterior/posterior pattern specification
InterPro Term Znf_C2H2-like, Znf_C2H2
Gene-Disease Assocation POLYDACTYLY, PREAXIAL IV, POLYDACTYLY, POSTAXIAL, TYPE A1, HYPOTHALAMIC HAMARTOMAS, GREIG CEPHALOPOLYSYNDACTYLY SYNDROME; GCPS, ACROCALLOSAL SYNDROME; ACLS, PALLISTER-HALL SYNDROME; PHS
UniProt Accession C9J9N4, P10071, F8WEV4
Search EB-eye ENSG00000106571
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-15765, E-GEOD-803, E-GEOD-22541, E-GEOD-6573, E-GEOD-7224, ... (26 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-17482, E-GEOD-5258, E-GEOD-19639, E-GEOD-18005, E-GEOD-2450, ... (38 experiments)

Factor Value U/D Experiments
MCF-7
1
3
E-GEOD-20081, E-GEOD-19639, E-GEOD-3529, E-GEOD-5823
SW480
1
3
E-MTAB-37, E-GEOD-18005, E-MEXP-1014, E-GEOD-2509
AGS
2
E-GEOD-15460, E-MTAB-37
MCF-10A
2
E-GEOD-14990, E-TABM-420
MOLT4
2
E-MTAB-37, E-MTAB-62
HCC827
1
E-MTAB-62
403 more value(s).


Cell type

studied in E-GEOD-22373, E-MEXP-2426, E-GEOD-21668, E-MEXP-66, E-GEOD-13909, ... (45 experiments)

Factor Value U/D Experiments
stromal cell
2
3
E-GEOD-1460, E-GEOD-3998, E-MEXP-1327, E-MEXP-2034, E-GEOD-10797 ... (5 experiments)
kidney cell
1
E-MEXP-1216
primary fibroblast
1
E-MEXP-66
basophil
1
E-GEOD-3982
n/a
1
E-MTAB-24
native fetal RPE
1
E-GEOD-18811
89 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-15960, E-GEOD-2466, E-GEOD-16363, E-GEOD-3678, ... (55 experiments)

Factor Value U/D Experiments
glioblastoma
3
E-MTAB-37, E-GEOD-4290, E-MTAB-62
prostate carcinoma
1
3
E-MEXP-2034, E-MTAB-62, E-TABM-26, E-MEXP-1327
rhabdomyosarcoma
2
E-MTAB-37, E-MTAB-62
uterine fibroid
2
E-MTAB-62, E-GEOD-7307
sarcoma
1
2
E-MTAB-62, E-MTAB-37, E-GEOD-2719
squamous cell lung carcinoma
1
E-GEOD-4127
153 more value(s).


Compound treatment

studied in E-GEOD-1615, E-GEOD-6907, E-GEOD-5741, E-GEOD-15205, E-GEOD-5824, ... (20 experiments)

Factor Value U/D Experiments
none
3
4
E-GEOD-5824, E-GEOD-412, E-GEOD-2292, E-GEOD-995, E-GEOD-5099, ... (7 experiments)
valproic acid
1
E-GEOD-1615
baseline sevoflurane
1
E-GEOD-4386
2,3-dimethoxy-1,4-naphthoquinone
1
E-GEOD-6907
control - keratinocyte growth factor
1
E-GEOD-7216
keratinocyte growth factor
1
E-GEOD-7216
26 more value(s).


Agent

studied in E-GEOD-19519

Factor Value U/D Experiments
tunicamycin
1
1
E-GEOD-19519
thapsigargin
1
1
E-GEOD-19519


Biopsy tissue
studied in E-GEOD-5851

Biosource provider
studied in E-MTAB-37

BioSourceProvider
studied in E-GEOD-19519, E-GEOD-19480

Blood/non-blood meta-groups
studied in E-MTAB-62

Bmngrd
studied in E-GEOD-20194, E-GEOD-16716

Cell treatment
studied in E-MEXP-1192

Cellular component
studied in E-GEOD-1400

Classifier
studied in E-GEOD-3493

Clinical history
studied in E-TABM-234, E-GEOD-19743, E-GEOD-7967, E-GEOD-21374, E-GEOD-21589, ... (7 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-19348, E-GEOD-22513, E-GEOD-21374, ... (9 experiments)

Clinical treatment
studied in E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-GEOD-19743, E-GEOD-20033, E-MEXP-2359, E-GEOD-6236, E-GEOD-4667, ... (7 experiments)

dfs time (months)
studied in E-GEOD-21653

Disease staging
studied in E-GEOD-89, E-GEOD-19743, E-GEOD-3325, E-GEOD-2509, E-TABM-147, ... (6 experiments)

Environmental stress
studied in E-GEOD-1643

Er
studied in E-GEOD-20194, E-GEOD-16716

Er ihc
studied in E-GEOD-21653

Estrogen receptor status
studied in E-GEOD-3494, E-GEOD-6532, E-GEOD-4922, E-GEOD-20194, E-GEOD-16716 ... (5 experiments)

Ethnic group
studied in E-GEOD-20194, E-GEOD-16716

Ethnicity
studied in E-GEOD-16363

family id
studied in E-GEOD-19519

Genetic modification
studied in E-GEOD-8023, E-MEXP-1482, E-GEOD-17385, E-GEOD-20847, E-GEOD-6431, ... (7 experiments)

Genotype
studied in E-TABM-1029, E-GEOD-22056, E-GEOD-3494, E-GEOD-17476, E-GEOD-21750, ... (10 experiments)

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-TABM-263, E-GEOD-13073, E-TABM-127, E-GEOD-20504, E-GEOD-19018, ... (7 experiments)

Her2 fish
studied in E-GEOD-20194, E-GEOD-16716

Histology
studied in E-TABM-234, E-GEOD-21653, E-TABM-276

Individual
studied in E-MTAB-197, E-TABM-325, E-GEOD-1926, E-MEXP-2069, E-GEOD-16363, ... (28 experiments)

Infection
studied in E-MEXP-1274, E-GEOD-12108, E-GEOD-12254, E-MEXP-561, E-GEOD-980 ... (5 experiments)

Initial distant metastases
studied in E-GEOD-22541

Injury
studied in E-GEOD-19743

Karyotype
studied in E-GEOD-12662

Ki67 ihc
studied in E-GEOD-21653

Labeling
studied in E-LGCL-5

Lymph node status
studied in E-GEOD-6532

Material type
studied in E-MEXP-455

Media
studied in E-MEXP-765

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

Observation
studied in E-TABM-276

organ
studied in E-GEOD-24283

Organism
studied in E-GEOD-1801, E-TABM-84

Organism status
studied in E-GEOD-19188

P53 ihc
studied in E-GEOD-21653

Pcr vs rd
studied in E-GEOD-20194, E-GEOD-16716

Performer
studied in E-GEOD-2004

Phase
studied in E-GEOD-4888

Phenotype
studied in E-GEOD-21750, E-GEOD-1460, E-GEOD-17636

Population
studied in E-GEOD-4922, E-GEOD-4342

Progesterone receptor status
studied in E-GEOD-3494, E-GEOD-6532, E-GEOD-20194, E-GEOD-16716

Protocol type
studied in E-GEOD-3254, E-GEOD-21837, E-GEOD-19445, E-GEOD-19246, E-GEOD-1343 ... (5 experiments)

Replicate
studied in E-GEOD-10896

RNAi
studied in E-MEXP-2115, E-GEOD-12438, E-MEXP-1509, E-GEOD-1676, E-MEXP-101, ... (7 experiments)

Sample preparation
studied in E-GEOD-16728

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-19743, E-GEOD-18995

sbr grade
studied in E-GEOD-21653

Sex
studied in E-GEOD-19069, E-GEOD-2466, E-GEOD-7307

Stimulation
studied in E-GEOD-20114, E-GEOD-11428

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-19188

Transfection
studied in E-GEOD-14680

Translocation cyclin group
studied in E-GEOD-2912

Treatment
studied in E-GEOD-16837, E-GEOD-19246

Treatments comments
studied in E-GEOD-20194, E-GEOD-16716

Tumor grading
studied in E-GEOD-4290, E-GEOD-3494, E-GEOD-22541, E-GEOD-4922

Vehicle
studied in E-GEOD-5258

Processing time: 0.399 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM